Pulmonary hypertension associated with ponatinib therapy

Eur Respir J. 2016 Feb;47(2):676-9. doi: 10.1183/13993003.01110-2015. Epub 2016 Jan 7.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Cardiac Output
  • Disease Progression
  • Female
  • Humans
  • Hypertension, Pulmonary / chemically induced*
  • Imidazoles / adverse effects*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Middle Aged
  • Pyridazines / adverse effects*
  • Ventricular Dysfunction, Right / chemically induced

Substances

  • Antineoplastic Agents
  • Imidazoles
  • Pyridazines
  • ponatinib